FCN: FTI Consulting, Inc. Stock

by  •  • Comments Off on FCN: FTI Consulting, Inc. Stock

SIC 8742 – Management Consulting Services

Valuation
Market Cap ($M) 5,768.48
Enterprise Value ($M) 5,107.99
Book Value ($M) 2,258.29
Book Value / Share 63.95
Price / Book 2.55
NCAV ($M) 480.97
NCAV / Share 13.62
Price / NCAV 11.99

Profitability (mra)
Return on Invested Capital (ROIC) 0.11
Return on Assets (ROA) 0.08
Return on Equity (ROE) 0.14

Liquidity (mrq)
Quick Ratio 1.95
Current Ratio 1.95

Balance Sheet (mrq) ($M)
Current Assets 1,819.51
Assets 3,596.83
Liabilities 1,338.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3,698.65
Operating Income 354.81
Net Income 280.09
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 395.10
Cash from Investing -10.16
Cash from Financing -15.38

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-27 13G/A Victory Capital Management Inc 3.88
2024-03-11 13G/A Vanguard Group Inc 10.00 0.53

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTIO
2024-10-24 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT
2024-07-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S
2024-04-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-28 26,000 193,077 13.47
2025-03-27 66,162 297,291 22.25
2025-03-25 43,596 208,339 20.93

(click for more detail)

Similar Companies
BAH – Booz Allen Hamilton Holding Corporation EVH – Evolent Health, Inc.
FC – Franklin Covey Co. G – Genpact Limited
GIB – CGI Inc.


Financial data and stock pages provided by
Fintel.io